Cargando…

REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS

Peritoneal exudate cells (PEC), obtained after the rejection of EL4 leukemia by BALB/c mice, are much more effective in the specific in vitro destruction of (51)Cr-labeled EL4 cells than are spleen, thymus, lymph node, or peripheral blood lymphocytes. The presence of a large number of effector cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Berke, Gideon, Sullivan, Karen A., Amos, Bernard
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1972
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139166/
https://www.ncbi.nlm.nih.gov/pubmed/5025438
_version_ 1782143732816019456
author Berke, Gideon
Sullivan, Karen A.
Amos, Bernard
author_facet Berke, Gideon
Sullivan, Karen A.
Amos, Bernard
author_sort Berke, Gideon
collection PubMed
description Peritoneal exudate cells (PEC), obtained after the rejection of EL4 leukemia by BALB/c mice, are much more effective in the specific in vitro destruction of (51)Cr-labeled EL4 cells than are spleen, thymus, lymph node, or peripheral blood lymphocytes. The presence of a large number of effector cells at the site of graft rejection is reflected in the potent cytolytic activity seen in vitro. Effector cells temporarily lose cytolytic reactivity when treated with trypsin but regain reactivity with time. This recovery occurs in normal as well as in immune serum. The destructive reactivity of PEC is increased when macrophages are removed. The remaining population of nonadherent PEC is composed primarily of small- to medium-sized lymphocytes. Complex tissue culture media are not needed, but there is a definite requirement for serum. The required serum component is heat stable, nondialyzable, and is not consumed during the reaction. The use of an ascites allograft system made these observations possible and permitted the isolation of those host cells intimately associated with rejection.
format Text
id pubmed-2139166
institution National Center for Biotechnology Information
language English
publishDate 1972
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21391662008-04-17 REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS Berke, Gideon Sullivan, Karen A. Amos, Bernard J Exp Med Article Peritoneal exudate cells (PEC), obtained after the rejection of EL4 leukemia by BALB/c mice, are much more effective in the specific in vitro destruction of (51)Cr-labeled EL4 cells than are spleen, thymus, lymph node, or peripheral blood lymphocytes. The presence of a large number of effector cells at the site of graft rejection is reflected in the potent cytolytic activity seen in vitro. Effector cells temporarily lose cytolytic reactivity when treated with trypsin but regain reactivity with time. This recovery occurs in normal as well as in immune serum. The destructive reactivity of PEC is increased when macrophages are removed. The remaining population of nonadherent PEC is composed primarily of small- to medium-sized lymphocytes. Complex tissue culture media are not needed, but there is a definite requirement for serum. The required serum component is heat stable, nondialyzable, and is not consumed during the reaction. The use of an ascites allograft system made these observations possible and permitted the isolation of those host cells intimately associated with rejection. The Rockefeller University Press 1972-06-01 /pmc/articles/PMC2139166/ /pubmed/5025438 Text en Copyright © 1972 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Berke, Gideon
Sullivan, Karen A.
Amos, Bernard
REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS
title REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS
title_full REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS
title_fullStr REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS
title_full_unstemmed REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS
title_short REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS
title_sort rejection of ascites tumor allografts : i. isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from balb/c mice immune to el4 leukosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139166/
https://www.ncbi.nlm.nih.gov/pubmed/5025438
work_keys_str_mv AT berkegideon rejectionofascitestumorallograftsiisolationcharacterizationandinvitroreactivityofperitoneallymphoideffectorcellsfrombalbcmiceimmunetoel4leukosis
AT sullivankarena rejectionofascitestumorallograftsiisolationcharacterizationandinvitroreactivityofperitoneallymphoideffectorcellsfrombalbcmiceimmunetoel4leukosis
AT amosbernard rejectionofascitestumorallograftsiisolationcharacterizationandinvitroreactivityofperitoneallymphoideffectorcellsfrombalbcmiceimmunetoel4leukosis